Last reviewed · How we verify

Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel

Massachusetts General Hospital · FDA-approved active Small molecule Quality 0/100

Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel is a Small molecule drug developed by Massachusetts General Hospital. It is currently FDA-approved. Also known as: Ziana, Ziana Gel.

At a glance

Generic nameClindamycin Phosphate 1.2% And Tretinoin 0.025% Gel
Also known asZiana, Ziana Gel
SponsorMassachusetts General Hospital
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel

What is Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel?

Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel is a Small molecule drug developed by Massachusetts General Hospital.

Who makes Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel?

Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel is developed and marketed by Massachusetts General Hospital (see full Massachusetts General Hospital pipeline at /company/massachusetts-general-hospital).

Is Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel also known as anything else?

Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel is also known as Ziana, Ziana Gel.

What development phase is Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel in?

Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel is FDA-approved (marketed).

Related